MedTrace Logo

HIBOC = Hepatic Imaging Biomarkers in Obese Children

NCT06463223 · Status: ENROLLING_BY_INVITATION · Type: OBSERVATIONAL · Enrollment: 300

Last updated 2026-05-18

No results posted yet for this study

Summary

The goal of this prospective, diagnostic observational study is to learn about how imaging based markers for components of liver disease appear in children with obesity. It aims to determine whether the imaging markers (ultrasound and MRI) for liver disease can be tools to improve diagnostics for liver affection in children with obesity and to ascertain how the markers are related to multiple clinical measures, for example BMI and serology measure, and treatment effects over time.

Conditions

  • Elastography
  • Shear Wave Elastography
  • Shear Wave Dispersion
  • Attenuation Imaging
  • Child Obesity
  • Metabolic Disease
  • Metabolic and Genetic Disorder Affecting the Liver
  • Fibrosis, Liver
  • Diagnosis
  • Inflammation; Liver
  • Steatosis

Sponsors & Collaborators

  • Sahlgrenska University Hospital

    lead OTHER

Eligibility

Min Age
9 Years
Max Age
14 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-02-01
Primary Completion
2029-12-31
Completion
2029-12-31

Countries

  • Sweden

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06463223 on ClinicalTrials.gov